KeyBanc analyst Scott Schoenhaus raised the firm’s price target on Veeva to $230 from $220 ahead of quarterly results. The firm cites improving company fundamentals, and keeps an Overweight rating on the shares.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on VEEV:
- 2 Stocks to Beat the Market – October 2023
- Oppenheimer tech/software analysts hold an analyst/industry conference call
- Salesforce launch of Pharma CRM to elevate debate on Veeva, says Morgan Stanley
- Veeva price target raised to $250 from $227 at Barclays
- Veeva price target raised to $227 from $204 at Truist